Halozyme
HALO
132 hedge funds and large institutions have $882M invested in Halozyme in 2014 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 36 reducing their positions, and 13 closing their positions.
108% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 13
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
19% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 36
9% more funds holding
Funds holding: 121 → 132 (+11)
9% more capital invested
Capital invested by funds: $810M → $882M (+$72.4M)
34% less call options, than puts
Call options by funds: $8.6M | Put options by funds: $13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$10.7M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.74M |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.04M |
| 4 |
Millennium Management
New York
|
+$3.67M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$3.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$18.2M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$7.42M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$2.58M |
| 4 |
HCM
Harvey Capital Management
Palm Beach,
Florida
|
-$2.4M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.65M |
HALO Hedge Fund Activity: Q4 2014 in Review
132 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2014, worth a combined $882M — up 8.9% from $810M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new HALO positions and 13 closed out — a net gain of 14 holders — while 43 added to existing stakes and 36 trimmed.
The largest buyer was Lombard Odier Asset Management (USA), adding an estimated $10.7M. The largest seller was QVT Financial, cutting an estimated $18.2M.
- 132 institutional investors held Halozyme (HALO) as of Q4 2014, up from 121 in Q3 2014.
- Funds reported $882M of Halozyme stock for Q4 2014, up 8.9% quarter-over-quarter.
- 27 funds opened new Halozyme positions in Q4 2014 and 13 closed out, a net change of +14 holders.
- The largest Halozyme buyer in Q4 2014 was Lombard Odier Asset Management (USA), an estimated $10.7M added.
- The largest Halozyme seller in Q4 2014 was QVT Financial, an estimated $18.2M sold.
Based on aggregated 13F filings for Q4 2014.